TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling
-
Published:2024-03-28
Issue:4
Volume:25
Page:1962-1986
-
ISSN:1469-3178
-
Container-title:EMBO Reports
-
language:en
-
Short-container-title:EMBO Rep
Author:
Amson Robert, Senff-Ribeiro Andrea, Karafin Teele, Lespagnol Alexandra, Honoré Joane, Baylot VirginieORCID, Banroques Josette, Tanner N Kyle, Chamond NathalieORCID, Dimitrov Jordan D, Hoebeke Johan, Droin Nathalie MORCID, Job Bastien, Piard Jonathan, Bommer Ulrich-AxelORCID, Choi Kwang-WookORCID, Abdelfatah SaraORCID, Efferth Thomas, Telerman Stephanie B, Geyer Felipe Correa, Reis-Filho Jorge, Telerman AdamORCID
Abstract
AbstractOncogenic intercellular signaling is regulated by extracellular vesicles (EVs), but the underlying mechanisms remain mostly unclear. Since TCTP (translationally controlled tumor protein) is an EV component, we investigated whether it has a role in genotoxic stress signaling and malignant transformation. By generating a Tctp-inducible knockout mouse model (Tctp–/f–), we report that Tctp is required for genotoxic stress-induced apoptosis signaling via small EVs (sEVs). Human breast cancer cells knocked-down for TCTP show impaired spontaneous EV secretion, thereby reducing sEV-dependent malignant growth. Since Trp53–/– mice are prone to tumor formation, we derived tumor cells from Trp53–/–;Tctp–/f– double mutant mice and describe a drastic decrease in tumori-genicity with concomitant decrease in sEV secretion and content. Remarkably, Trp53–/–;Tctp–/f– mice show highly prolonged survival. Treatment of Trp53–/– mice with sertraline, which inhibits TCTP function, increases their survival. Mechanistically, TCTP binds DDX3, recruiting RNAs, including miRNAs, to sEVs. Our findings establish TCTP as an essential protagonist in the regulation of sEV-signaling in the context of apoptosis and tumorigenicity.
Funder
Institut National Du Cancer Agence Nationale de la Recherche LabEx Lermit Odyssea fund Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Science without Borders Federal University of Parana Fellowship from MESR, Ecole Doctorale de Cancérologie Paris XI
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10:619–624 2. Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J et al (2012) Reciprocal repression between P53 and TCTP. Nat Med 18:91–99 3. Amson R, Pece S, Marine JC, Di Fiore PP, Telerman A (2013) TPT1/TCTP-regulated pathways in phenotypic reprogramming. Trends Cell Biol 23:37–46 4. Amson RB, Nemani M, Roperch JP, Israeli D, Bougueleret L, Le Gall I, Medhioub M, Linares-Cruz G, Lethrosne F, Pasturaud P et al (1996) Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci USA 93:3953–3957 5. Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, Goud B, Amson R, Telerman A (2004) TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem 279:46104–46112
|
|